HK Doctors Prefer Chinese Covid Vaccine: Survey

"); jQuery("#212 h3").html("

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1571820_1_20210122181304.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1571820-20210122.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1571820-20210122.htm', 'DCS.dcsqry', '' ); } } }); }); });
2021-01-22 HKT 16:18
A pro-government healthcare workers' group and four unions in the medical sector say a survey they've carried out suggests Hong Kong doctors, nurses and dentists prefer China's Sinovac coronavirus jabs to those developed overseas.
Medical Conscience said on Friday that they polled 930 healthcare workers, including 444 doctors and 318 dentists, regarding the three vaccines the Hong Kong government has procured so far.
Sixty-one percent said their preferred vaccine would be the one made by Sinovac, while 22 percent opted for the one made by Germany's BioNTech and 11 percent the jab from Anglo-Swedish company AstraZeneca.
Five percent of the respondents said they would refuse to take Covid-19 vaccines altogether.
Medical Conscience said the survey was carried out between January 7 and January 14.
Researchers in Brazil only made public the findings of their late-stage trials of the Sinovac jabs on January 13, saying it has an efficacy rate of 50.4 percent - lower than those of the other two.
But Dr David Lam from Medical Conscience said many in the medical sector already knew that Sinovac was their favourite, because it is made in a more conventional way, using inactivated virus particles.
"Maybe doctors and nurses are kind of more conservative people so they choose something they know well. That’s probably the reason why more people chose the inactivated virus technology," Lam said at a press conference.
"I wouldn’t really put too much emphasis on the branding of the vaccines, but rather the technology behind them."
Lam also said he has no problem with the government’s plan to prioritise care home residents and staff over healthcare workers when the inoculation programme is launched.
He said while he believes doctors and nurses should be among the first groups of people to get the jabs, they don't need to be right at the front of the queue because they are well-trained and can protect themselves using their professional knowledge.
HashKey Capital Partners With Tiantu AM To Explore Virtual Asset Funds
HashKey Capital has signed a memorandum of strategic collaboration with Tiantu Asset Management (Tiantu AM), a wholly o... Read more
You Can Now Make Alipay Payments With AR Glasses
RayNeo and Ant Group have announced a partnership to develop digital payment solutions for global use. The collaboratio... Read more
JICA Goes Live With Finastras Loan IQ In First Japan Deployment
Finastra has announced that the Japan International Cooperation Agency (JICA) has gone live with its Loan IQ platform. ... Read more
Japan Set To Approve First Yen-Backed Stablecoin
Japan’s Financial Services Agency (FSA) is preparing to approve the issuance of the country’s first yen-backed stab... Read more
Indonesia And China Begin Trials For Cross-Border QRIS Payments
Bank Indonesia (BI) and the People’s Bank of China (PBOC) have begun a series of trials for cross-border QR code paym... Read more
ANZ Appoints Ender Tanar As Japan Country Head
ANZ, headquartered in Melbourne, Australia, announced the appointment of Ender Tanar as Country Head for Japan, reporti... Read more